Plain-English translation of NCT06966908 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is designed to improve how hospitals find and care for people with chronic hepatitis B infection. For eligible patients who need antiviral therapy, the study also measures how the treatment affects your quality of life—including your physical symptoms, emotional wellbeing, beliefs about your condition, and how you feel socially—over the course of 48 weeks.
Many people with chronic hepatitis B don't know they have the condition or don't receive specialist care. This trial aims to fix that by creating a better system for finding these patients within hospitals and connecting them with specialized hepatitis B clinics. The quality-of-life portion helps doctors understand whether this treatment truly improves how patients feel day-to-day, not just the virus numbers.
You likely qualify if…
You likely don't qualify if…
If you're identified as having hepatitis B through a hospital test, a study nurse will contact you to explain the program and encourage you to visit the Hepatitis B Health Clinic. If you enroll in the quality-of-life sub-study, you'll complete brief health questionnaires at the start of treatment, after 24 weeks, and after 48 weeks to help doctors understand how the treatment is affecting your physical symptoms, emotions, and social well-being. The entire follow-up period lasts about 48 weeks, and the study team will help guide you through specialist care.
AI-generated summary from trial data · Jul 17, 2026 · Not medical advice
China